JAMA Oncol:多喝咖啡还能减少结直肠癌死亡,延长生存期

2020-09-20 生物世界 Bio生物世界

通过对大型临床试验数据的进一步分析,发现对于晚期和转移性结直肠癌患者,每天喝2-3杯咖啡的患者总体生存期更长,癌症恶化风险更低,每天喝4杯咖啡的患者收益更大。

2020年9月17日,梅奥医学中心、Dana-Farber癌症研究所等国际顶尖医学研究机构合作,在顶级医学期刊 JAMA Oncology 杂志发表研究论文,通过对大型临床试验数据的进一步分析,发现对于晚期和转移性结直肠癌患者,每天喝2-3杯咖啡的患者总体生存期更长,癌症恶化风险更低,每天喝4杯咖啡的患者收益更大。

过去几年的多项研究表明,定期喝咖啡可以带来很多健康益处。其中一个引人注意的好处是喝咖啡能够降低癌症风险。

多喝咖啡可减少因肝癌死亡的人数

澳大利亚多个研究机构合作,在 Alimentary Pharmacology and Therapeutics 杂志发表论文,通过对全球疾病负担数据集的分析,表明随着咖啡摄入量的增加,全球范围内肝癌相关死亡率下降,具体来说,如果世界上每人每天至少喝两杯咖啡,全世界因肝癌而死亡的人数将减少超过45万,如果每人每天至少喝四杯咖啡,因肝癌而死亡的人数则将减少超过72万。

多喝咖啡可降低多种慢性病风险

四大医学期刊之首的《新英格兰医学杂志》(NEJM)发表了题为:Coffee, Caffeine, and Health 的综述论文。该论文指出,大量证据提示饮用咖啡不会增加血管疾病和癌症风险,而且每日饮用3~5杯咖啡与数种慢性疾病风险降低相关。

多喝咖啡与延长结直肠癌患者寿命有关

2020年9月17日,梅奥医学中心、Dana-Farber癌症研究所等国际顶尖医学研究机构合作,在顶级医学期刊 JAMA Oncology 杂志发表了题为:Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer 的研究论文。

研究团队对一项大型结直肠癌患者临床试验的观察数据进行进一步分析,发现在接受治疗的1171名转移性结直肠癌患者中,每天喝2-3杯咖啡的患者总体生存期更长,癌症恶化风险更低,每天喝4杯咖啡的患者收益更大。

该论文的数据来自一项III期临床试验:比较先前未治疗的局部晚期或转移性结直肠癌患者在标准化疗中添加西妥昔单抗和/或贝伐单抗的治疗情况。作为临床试验的一部分,研究人员通过问卷调查了这些患者的饮食摄入量,包括咖啡摄入量。数据收集自2005年10月27日至2018年1月18日,研究人员将该数据与治疗后癌症进程的信息相关联。

之前已经知道咖啡中的几种化合物具有抗氧化、抗炎作用,以及可能对癌症有效的特性,流行病学研究发现,咖啡摄入量增加与晚期结直肠癌患者的生存率提高有关,但尚无咖啡因与转移性疾病患者生存率之间关系的证据。

研究人员发现,与不喝咖啡的患者相比,每天喝2-3杯咖啡的患者总体生存期更长,癌症恶化风险更低,每天喝4杯咖啡的患者收益更大。

咖啡摄入量与结直肠癌患者总生存期

咖啡摄入量与结直肠癌患者的无进展生存期

研究人员表示,这些发现能够在喝咖啡与降低结直肠癌患者癌症发展和死亡风险之间建立联系,但这些数据还不足以建立二者之间的因果关系。 因此,建议多喝咖啡来作为结直肠癌的潜在治疗手段还为时过早,但这项研究表明,喝咖啡不但无害,而且很可能有许多益处。

最后,该研究的通讯作者 Kimmie Ng 表示,这项研究进一步支持了饮食和其他可调节因素在结直肠癌患者治疗中的重要性。现在还需要进一步的研究以确定咖啡摄入量与结直肠患者改善结局之间是否存在因果关系,以及具体是咖啡中的哪些物质带来的这种好处。

原始出处:

Christopher Mackintosh, MLA1; Chen Yuan, ScD2; Fang-Shu Ou, PhD3; et al.Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer.JAMA Oncol. Published online September 17, 2020. doi:10.1001/jamaoncol.2020.3938

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2021-03-11 148a8a94m50暂无昵称

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2021-07-01 minlingfeng
  3. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-09-20 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-09-20 anti-cancer

    谢谢梅斯分享这么多精彩信息

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-09-20 ms2000001921731409

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-09-20 ms3000001109849787

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-09-20 ms1000000223698072

    whatever whatever whateve coffee whatever whatever whateve coffee coffe

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=947512, encodeId=a6fa94e512fd, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb0d5320345, createdName=148a8a94m50暂无昵称, createdTime=Thu Mar 11 22:10:36 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865909, encodeId=8dba186590953, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Jul 01 01:20:45 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1378257, encodeId=823a13e825792, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69004, encryptionId=c29b69004f9, topicName=生存期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453421, encodeId=f6ae145342144, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Tue Sep 22 02:20:45 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036271, encodeId=ec6410362e1ec, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038111, encodeId=a22f1038111bb, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Sun Sep 20 14:20:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886830, encodeId=5002886830e1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34c5419838, createdName=ms2000001921731409, createdTime=Sun Sep 20 12:00:45 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886828, encodeId=74ac8868280a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f75419831, createdName=ms3000001109849787, createdTime=Sun Sep 20 11:36:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886826, encodeId=ebd18868268d, content=whatever whatever whateve coffee whatever whatever whateve coffee coffe, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:26:07 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886825, encodeId=f5af886825f9, content=什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200810/413f8b33b4e34dcd82cbfc3ffd0f8c3c/4393e48ea913472084d5677670d3b48b.jpg, createdBy=b52c5409947, createdName=ms1000000223698072, createdTime=Sun Sep 20 11:24:41 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-09-20 ms1000000223698072

    什么类型种类的咖啡都可以吗?有没有对咖啡种类有定义?

    0

相关资讯

JAMA Oncology:结直肠癌同期孤立腹膜转移早期切除术后全身辅助化疗与积极监测的疗效比较

据统计,在全世界约430个治疗中心中,约有四分之一的结直肠癌同期孤立腹膜转移患者接受了细胞减灭术和腹腔热灌注化疗。一个国际上存在争议的话题是结直肠癌同期孤立腹膜转移患者是否应该接受全身辅助化疗。

CELL:颠覆传统观念,染色质拓扑变化可抑制结直肠癌的恶性进展

最近,研究人员在CELL杂志发文,将结肠肿瘤和正常结肠的拓扑图与表观遗传学、转录和成像数据整合在一起,以表征染色质环、拓扑相关域和大规模隔室的改变。

Cell Death Dis:FXR通过拮抗Wnt/β-catenin信号发挥抑癌作用

结直肠癌(CRC)作为癌症相关死亡的第二大主要原因,全球每年约有1,800,000例新病例被确诊为CRC。尽管目前在CRC的治疗上已取得了较大的进展,但由于晚期CRC患者的肿瘤远端转移和复发,该疾病的

Stem Cell Reports:男性更易患结直肠癌,这与雄性激素水平有关

据世界卫生组织(WHO)最新统计,结直肠癌是全球范围内发病率排名第三、致死率排名第二的癌种。结直肠癌可能发生在任何年龄,但大多只影响老年人,它通常开始于结肠内部形成的称为息肉的小而良性的细胞团。

DCR:二甲双胍作为放射增敏剂在直肠癌新辅助治疗中的作用

二甲双胍是治疗Ⅱ型糖尿病最常用的处方药,因为它可以它通过抑制肝脏葡萄糖的产生而具有降低血糖的作用,是目前全球应用最广泛的口服降糖药之一。

Nat Commun:哪些局部晚期直肠癌患者才能从化疗中获益?

辅助化疗只能降低DM的风险,并只在某些亚组患者中提供额外的生存获益,还有一些患者在治疗后甚至可能获得更糟糕的结果。因此,如何检测出可以从辅助化疗中获益的LARC患者至关重要。